Effects of Morphine on Testosterone Levels in Rat C6 Glioma Cells: Modulation by Anastrozole

被引:13
作者
Ceccarelli, Ilaria [1 ]
Rossi, Antonella [2 ]
Maddalena, Melinda [1 ]
Weber, Elisabetta [2 ]
Aloisi, Anna Maria [1 ]
机构
[1] Univ Siena, Dept Physiol, Neurosci & Appl Physiol Sect, I-53100 Siena, Italy
[2] Univ Siena, Dept Neurosci, Mol Med Sect, I-53100 Siena, Italy
关键词
CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; AROMATASE; BETA; EXPRESSION; ESTRADIOL; NEURONS; PLASMA; ALPHA; DEATH;
D O I
10.1002/jcp.21830
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rat C6 glioma cells are commonly used to investigate the functions of glial cells. To evaluate the presence of testosterone and its metabolism in rat C6 glioma cells, we cultured them in media with or without the addition of testosterone propionate and anastrozole, a blocker of aromatase, the enzyme needed to transform testosterone into estradiol. The same procedure was repeated with morphine (10 and 100 mu M), known to decrease testosterone levels in the brain (in rats) and plasma (in rats and humans). Confluent cells were exposed to the test media for 48 h and then collected. Cell pellets were used to determine testosterone by radioimmunoassay. The C6 cells contained detectable levels of testosterone and the levels increased with the addition of testosterone to the medium. Aromatase blockage by anastrozole increased cellular levels of testosterone regardless of the addition of exogenous testosterone. Both concentrations of morphine dose-dependently decreased testosterone levels in the C6 cells; this effect was also present with the contemporary administration of anastrozole. Our findings show that testosterone is present in rat C6 glioma cells and can be metabolized by aromatase. Moreover, the presence of morphine in the culture medium strongly decreased testosterone, demonstrating that the glia would be a target of the morphine-induced hypogonadal effect. J. Cell. Physiol. 221: 1-4, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 29 条
[1]   Endocrine consequences of long-term intrathecal administration of opioids [J].
Abs, R ;
Verhelst, J ;
Maeyaert, J ;
Van Buyten, JP ;
Opsomer, F ;
Adriaensen, H ;
Verlooy, J ;
Van Havenbergh, T ;
Smet, M ;
Van Acker, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) :2215-2222
[2]   Androgen treatment of neonatal rats decreases susceptibility of cerebellar granule neurons to oxidative stress in vitro [J].
Ahlbom, E ;
Grandison, L ;
Bonfoco, E ;
Zhivotovsky, B ;
Ceccatelli, S .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (04) :1285-1291
[3]   Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF) [J].
Aloisi, AM ;
Pari, G ;
Ceccarelli, I ;
Vecchi, I ;
Ietta, F ;
Lodi, L ;
Paulesu, L .
PAIN, 2005, 115 (1-2) :142-151
[4]   Sex hormones, central nervous system and pain [J].
Aloisi, Anna Maria ;
Bonifazi, Marco .
HORMONES AND BEHAVIOR, 2006, 50 (01) :1-7
[5]   In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure [J].
Amini, H ;
Ahmadiani, A .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2005, 23 (07) :621-626
[6]   Aromatase expression by reactive astroglia is neuroprotective [J].
Azcoitia, I ;
Sierra, A ;
Veiga, S ;
Garcia-Segura, LM .
STEROIDS AND THE NERVOUS SYSTEM, 2003, 1007 :298-305
[7]  
Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1
[8]   Neuroprotection against oxidative stress by estrogens: Structure-activity relationship [J].
Behl, C ;
Skutella, T ;
Lezoualch, F ;
Post, A ;
Widmann, M ;
Newton, CJ ;
Holsboer, F .
MOLECULAR PHARMACOLOGY, 1997, 51 (04) :535-541
[9]   17-BETA ESTRADIOL PROTECTS NEURONS FROM OXIDATIVE STRESS-INDUCED CELL-DEATH IN-VITRO [J].
BEHL, C ;
WIDMANN, M ;
TRAPP, T ;
HOLSBOER, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) :473-482
[10]  
Bohn LM, 1998, J NEUROCHEM, V70, P1819